Antibody-drug Conjugates
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
23
NCT03605719
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
Phase: Phase 1
Role: Collaborator
Start: Oct 24, 2018
Completion: Oct 10, 2022
Loading map...